B-CELL MALIGNANCY

Clinical trials for B-CELL MALIGNANCY explained in plain language.

Never miss a new study

Get alerted when new B-CELL MALIGNANCY trials appear

Sign up with your email to follow new studies for B-CELL MALIGNANCY, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 3 Not yet recruiting 1

New hope for blood cancer patients: experimental drug HRS-3005 enters first human trials

Disease control Not yet recruiting

This early-stage study tests a new drug called HRS-3005 in about 190 adults with certain blood cancers (B-cell malignancies) that have come back or not responded to other treatments. The main goals are to check the drug's safety, find the best dose, and see if it helps shrink tum…

Matched conditions: B-CELL MALIGNANCY

Phase: PHASE1 • Sponsor: Jiangsu HengRui Medicine Co., Ltd. • Aim: Disease control

Last updated May 01, 2026 15:56 UTC

B-CELL MALIGNANCY

Get alerted when new B-CELL MALIGNANCY trials appear

New hope for blood cancer patients: experimental drug HRS-3005 enters first human trials